What are the benefits of using ticagrelor in patients with prior myocardial infarction?
The use of ticagrelor in patients with prior myocardial infarction has been found to be beneficial in preventing stroke. This is based on insights from the PEGASUS-TIMI 54 study, a randomized, double-blind, placebo-controlled trial which studied the effects of ticagrelor on the prevention of cardiovascular events in patients with prior heart attack. Results of the study showed that ticagrelor reduced the risk of stroke in this population. Additionally, it also reduced the risk of all-cause mortality and major bleeding events.  